FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

385275000: forme pharmaceutique pour usage transdermique et/ou cutané (valeur de l'attribut)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    436351000077118 forme pharmaceutique pour usage transdermique et/ou cutané (valeur de l'attribut) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form est un(e) (attribut) type de préparation médicamenteuse false Inferred relationship Some
    Cutaneous AND/OR transdermal dosage form est un(e) (attribut) Dose form by site prepared for false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Mometasone furoate 1 mg/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Mometasone furoate 1 mg/g cutaneous lotion a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Fluticasone propionate 500 microgram/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar+salicylic acid ointment BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 10% paint (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 7.5% paste BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Zinc+coal tar paste BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar ointment BPC (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Strong coal tar 40% solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 10 mg/mL cutaneous lotion a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 40% bath emulsion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Strong coal tar solution+pine tar 5/5% gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 10 mg/mL cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar solution 10% cream (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Allantoin 20 mg/g and coal tar extract 50 mg/g cutaneous lotion a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 20% solution BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dithranol+salicylic acid 0.25%/1.6% scalp gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Ichthammol 10% ointment BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Zinc+ichthammol cream BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid 2% ointment BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Zinc+salicylic acid paste BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Zinc+salicylic acid paste half strength (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Calcipotriol 50 microgram/mL cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Calcipotriene 0.005% solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tacalcitol (as tacalcitol monohydrate) 4 microgram/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tazarotene 0.05% aqueous gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tazarotene 0.1% aqueous gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.1% ointment BP a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.2% ointment BP a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.5% ointment BP a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 1.5% ointment BP a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.2% paste BP a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.5% paste BP a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely dithranol 20 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 30 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.1% paste BP a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 1% paste BP a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely dithranol 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 5 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 10 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 1 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.2% cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.4% cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Aluminum oxide 52.2% paste (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Aluminium oxide 381 mg/g cutaneous paste a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide+potassium hydroxyquinoline sulfate 5/0.5% lotio-gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sulfur+salicylic acid cream BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sulfur+salicylic acid ointment BPC (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tretinoin 250 microgram/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tretinoin 100 microgram/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tretinoin 500 microgram/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tretinoin 250 microgram/g cutaneous lotion a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Clindamycin 1% roll-on lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Clindamycin 1% topical alcoholic solution (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 40 milligram/1 gram conventional release cutaneous cream (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 50 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 100 mg/g cutaneous lotion a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 2.5% aqueous gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 5% aqueous gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 10% aqueous gel (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 10% wash (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid collodion BP 12% (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid+boric acid in purified talc 3%/5% powder (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid+zinc oxide 5%/20% dusting powder (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid in white soft paraffin 60%/40% ointment (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid 17% liquid (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid 110 mg/g cutaneous gel a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid+lactic acid 16.7%/16.7% paint (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Bromine complexes (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Formaldehyde 36% lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Formaldehyde 10% lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Formaldehyde 15% lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Formaldehyde lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Podophyllin compound 15% paint BP (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Podophyllotoxin 5 mg/mL cutaneous solution a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Podophyllotoxin 1.5 mg/g cutaneous cream a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dimethyl-ether propane aerosol (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Toughened silver nitrate BP 95% stick (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Aminobenzoic acid lotion (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Camouflaging preparations (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely povidone iodine 40 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar extract 2% shampoo (product) a une forme pharmaceutique (attribut) False Cutaneous AND/OR transdermal dosage form Inferred relationship Some

    Start Previous Page 4 of 13 Next End


    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start